Scientists scan brains of people with autism and Fragile-X to see how they work
NCT ID NCT02719951
First seen Jan 10, 2026 · Last updated Jun 10, 2026 · Updated 17 times
Summary
This study used a special brain scan (PET imaging) to look at how a chemical messenger called glutamate works in the brains of people with autism, people with Fragile-X syndrome, and healthy volunteers. The goal was to better understand brain signaling differences in these conditions. 27 men aged 18 to 45 took part in the study, which did not test any treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Tours
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.